Rankings
▼
Calendar
JBIO (Jade Biosciences, Inc.) Stock Financials & Earnings | Market Cap Arena
JBIO
Jade Biosciences, Inc.
Mkt Cap
$491M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$127M
EPS (TTM)
-$5.46
Free Cash Flow (TTM)
-$104M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Next: Q1 2026 · Mar 26
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q3 23
$0
-$25K
-$21M
Q4 23
$0
-$28K
-$22M
Q1 24
$0
-$28K
-$25M
Q2 24
$0
-$28K
-$26M
Q3 24
$0
$0
-$15M
Q4 24
$0
-$8K
-$6M
Q1 25
$0
-$4K
-$3M
Q2 25
$0
-$1K
-$28M
Q3 25
$0
-$12K
-$27M
Q4 25
$0
$0
-$35M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q3 23
-$16M
-$16M
Q4 23
-$15M
-$15M
Q1 24
-$24M
-$24M
Q2 24
-$20M
-$20M
Q3 24
$37M
$37M
Q4 24
-$11M
-$11M
Q2 25
-$37M
-$37M
Q3 25
-$22M
-$22M
Q4 25
-$34M
-$34M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q3 23
$32K
Q4 23
$64K
Q1 24
$0
Q2 24
$0
Q3 24
$0
Q4 24
$0
Q2 25
$136K
Q3 25
$57K
Q4 25
$3K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q3 24
—
-30.0%
Q4 24
—
-71.0%
Q1 25
—
-86.2%
Q2 25
—
+6.2%
Q3 25
—
+83.1%
Q4 25
—
+445.1%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q3 23
$0
—
Q4 23
$0
—
Q1 24
$0
—
Q2 24
$0
—
Q3 24
$0
—
Q4 24
$0
—
Q2 25
$0
—
Q3 25
$4M
—
Q4 25
$0
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q3 23
$17M
—
$4M
Q4 23
$18M
—
$4M
Q1 24
$20M
—
$5M
Q2 24
$21M
—
$5M
Q3 24
$14M
—
$1M
Q4 24
$2M
—
$5M
Q1 25
—
—
$3M
Q2 25
$23M
$5M
—
Q3 25
$22M
—
$5M
Q4 25
$29M
—
$6M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q3 23
$32M
$103M
$135M
Q4 23
$23M
$99M
$122M
Q1 24
$9M
$90M
$99M
Q2 24
$31M
$73M
$104M
Q3 24
$31M
$58M
$89M
Q4 24
$34M
$45M
$79M
Q1 25
$44M
$32M
$76M
Q2 25
$221M
$0
$221M
Q3 25
$50M
$149M
$199M
Q4 25
$0
$248M
$248M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q3 23
790K
—
Q4 23
791K
+0.2%
Q1 24
794K
+0.4%
Q2 24
822K
+3.5%
Q3 24
3M
+284.1%
Q4 24
828K
-73.8%
Q1 25
828K
+0.0%
Q2 25
28M
+3333.1%
Q3 25
40M
+39.2%
Q4 25
49M
+24.6%
marketcaparena.com